Lennie Derde

Hivatkozott rá

	Összes	2020 óta
Hivatkozások	31360	22158
h-index	39	36
i10-index	55	53

6000

3000

1500

4500

20092010201120122013201420152016201720182019202020212022202320242025141 306 424 556 720 854 973 1110 1124 1246 1311 3313 4992 5538 4219 3489 370

Nyilvános hozzáférés

Összes megtekintése

41 cikk

2 cikk

elérhető

nem érhető el

Finanszírozási megbízások alapján

Társszerzők

christian brun-buissonEpidemiology & Modeling of bacterial Evasion to Antimicrobials - Institut Pasteur, ParisE-mail megerősítve itt: aphp.fr
Matteo BassettiChair Infectious Diseases Clinic, University of Genoa and San Martino HospitalE-mail megerősítve itt: unige.it
Georgios PetrikkosEuropean University Cyprus , National KapodistrianE-mail megerősítve itt: euc.ac.cy
Ben CooperOxford UniversityE-mail megerősítve itt: tropmedres.ac
Helen GiamarellouProfessor of Internal Medicine, National and Kapodistrian University of Athens, Medical SchoolE-mail megerősítve itt: med.uoa.gr
surbhi malhotra-kumarProfessor of Medical Microbiology, Universiteit AntwerpenE-mail megerősítve itt: uantwerpen.be
Djillali AnnaneAPHPE-mail megerősítve itt: aphp.fr
Uga DumpisProfessor Infectious Diseases, University of Latvia, Head of Department of Infectious DiseasesE-mail megerősítve itt: stradini.lv
Alexis TabahThe University of Queensland, Queensland University of Technology, Redcliffe Hospital, MNHHSE-mail megerősítve itt: uq.edu.au
Andrew Conway Morris, MB ChB (hon...Associate Professor of Anaesthesia / Honorary Consultant, University of CambridgeE-mail megerősítve itt: cam.ac.uk
Olaf CremerProfessor, Department of Intensive Care Medicine, University Medical Center UtrechtE-mail megerősítve itt: umcutrecht.nl
Willems, RUniversity Medical Center UtrechtE-mail megerősítve itt: umcutrecht.nl
keyvan RazaziRéanimation médicale Hôpital Henri MondorE-mail megerősítve itt: aphp.fr
Yehuda CarmeliNational Institute of Antibiotic Resistance and Infection Control, 6 Weizmann St. Tel Aviv, IsraelE-mail megerősítve itt: tlvmc.gov.il
Waleed AlhazzaniMODHS, Imam Abdulrahman Bin Faisal University, Saudi ArabiaE-mail megerősítve itt: mod.gov.sa
Kostas PapagiannitsisAssistant Professor of Microbiology, Faculty of Medicine, University Of Thessaly, GreeceE-mail megerősítve itt: uth.gr
ANTONIADOU ANASTASIANational and Kapodistrian University of Athens, School of MedicineE-mail megerősítve itt: med.uoa.gr
Yaseen M Arabi, MD, FCCP, FCCM, A...King Saud bin Abdulaziz University for Health SciencesE-mail megerősítve itt: mngha.med.sa

Követés

Lennie Derde

Clinician Researcher, University Medical Center Utrecht

E-mail megerősítve itt: umcutrecht.nl

ICU infectious diseases pneumonia sepsis trial design


Cím Rendezés hivatkozások szerint Rendezés év szerint Rendezés cím szerint	Hivatkozott rá Hivatkozott rá	Év
World malaria report 2023 World Health Organization World Health Organization, 2023	15724*	2023
Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19) W Alhazzani, MH Møller, YM Arabi, M Loeb, MN Gong, E Fan, ... Intensive care medicine 46, 854-887, 2020	4007	2020
Interleukin-6 receptor antagonists in critically ill patients with Covid-19–preliminary report Remap-Cap Investigators, AC Gordon, PR Mouncey, F Al-Beidh, ... MedRxiv, 2021.01. 07.21249390, 2021	1487	2021
A minimal common outcome measure set for COVID-19 clinical research JC Marshall, S Murthy, J Diaz, NK Adhikari, DC Angus, YM Arabi, K Baillie, ... The lancet infectious diseases 20 (8), e192-e197, 2020	1193	2020
Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19 ATTACC, ACTIV-4a, and REMAP-CAP Investigators New England Journal of Medicine 385 (9), 790-802, 2021	1149	2021
Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial DC Angus, L Derde, F Al-Beidh, D Annane, Y Arabi, A Beane, ... Jama 324 (13), 1317-1329, 2020	890	2020
Interleukin-6 receptor antagonists in critically ill patients with Covid-19 Remap-Cap Investigators New England Journal of Medicine 384 (16), 1491-1502, 2021	674	2021
Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis P Domingo, I Mur, GM Mateo, M del Mar Gutierrez, V Pomar, N de Benito, ... Jama 326 (6), 499-518, 2021	530	2021
Antimicrobial resistance and the United Nations sustainable development cooperation framework: Guidance for United Nations Country teams World Health Organization World Health Organization, 2021	449	2021
Surviving sepsis campaign guidelines on the management of adults with coronavirus disease 2019 (COVID-19) in the ICU: first update W Alhazzani, L Evans, F Alshamsi, MH Møller, M Ostermann, HC Prescott, ... Critical care medicine 49 (3), e219-e234, 2021	442	2021
Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial LPG Derde, BS Cooper, H Goossens, S Malhotra-Kumar, RJL Willems, ... The Lancet infectious diseases 14 (1), 31-39, 2014	442	2014
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials C Axfors, AM Schmitt, P Janiaud, J Van’t Hooft, S Abd-Elsalam, EF Abdo, ... Nature communications 12 (1), 2349, 2021	376	2021
The REMAP-CAP (randomized embedded multifactorial adaptive platform for community-acquired pneumonia) study. Rationale and design DC Angus, S Berry, RJ Lewis, F Al-Beidh, Y Arabi, W van Bentum-Puijk, ... Annals of the American Thoracic Society 17 (7), 879-891, 2020	374	2020
Personal protective equipment and intensive care unit healthcare worker safety in the COVID-19 era (PPE-SAFE): An international survey A Tabah, M Ramanan, KB Laupland, N Buetti, A Cortegiani, J Mellinghoff, ... Journal of critical care 59, 70-75, 2020	360	2020
A guide to immunotherapy for COVID-19 FL van de Veerdonk, E Giamarellos-Bourboulis, P Pickkers, L Derde, ... Nature medicine 28 (1), 39-50, 2022	322	2022
Adaptive platform trials: definition, design, conduct and reporting considerations Nature Reviews Drug Discovery 18 (10), 797-807, 2019	284	2019
ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia I Martin-Loeches, A Torres, B Nagavci, S Aliberti, M Antonelli, M Bassetti, ... Intensive care medicine 49 (6), 615-632, 2023	211	2023
Effect of convalescent plasma on organ support–free days in critically ill patients with COVID-19: a randomized clinical trial H Abdelhady, M Abdelrazik, Z Abdi, D Abdo, A Abdulle, L Abel, ... Jama 326 (17), 1690-1702, 2021	209	2021
Clinical impact and risk factors for colonization with extended-spectrum β-lactamase-producing bacteria in the intensive care unit K Razazi, LPG Derde, M Verachten, P Legrand, P Lesprit, C Brun-Buisson Intensive care medicine 38, 1769-1778, 2012	190	2012
Chlorhexidine body washing to control antimicrobial-resistant bacteria in intensive care units: a systematic review LPG Derde, MJD Dautzenberg, MJM Bonten Intensive care medicine 38, 931-939, 2012	165	2012

A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.

Cikkek 1–20

Hivatkozások évente

Ismétlődő hivatkozások

Összevont hivatkozások

Társszerzők hozzáadásaTársszerzők

Követés

Hivatkozott rá

Társszerzők